Patients receiving ACE inhibitors, beta-blockers and a captopril dose <75 mg/day 3 days after admission were also excluded from the study. Other criteria for exclusion were a serum creatinine ...

Objective: To verify the feasibility, tolerability and efficacy of the combination of captopril (75 mg/day) and candesartan (8 mg/day) in early postinfarction phases of not thrombolysed and ...

Captopril was a game-changer. Originally released in the 1980s, captopril was the first ACE (angiotensin-converting enzyme) ...